SciELO - Scientific Electronic Library Online

 
vol.12 número8Mamografía en el diagnóstico precoz de cáncer de mama en mujeres de 40-49 años con riesgo medio de padecer la enfermedadReacciones adversas neurológicas asociadas a ciprofloxacino índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

Compartir


Medifam

versión impresa ISSN 1131-5768

Resumen

SANCHEZ LITE, I.; CAL DE LA FUENTE, A. de la; FRUTOS LLANES, R.  y  CANO DEL POZO, M.. Are we aware of the side effects of the drugs we prescribe? . Medifam [online]. 2002, vol.12, n.8, pp.75-78. ISSN 1131-5768.

Many of the medicines used daily and which are supposed harmless, may in fact produce numerous side-effects which can, on occasions, be life-threatening. Agranulocytosis is an uncommon alteration of the blood consisting of severe neutropenia with serious associated infections and a high mortality rate. A great number of medications have been associated with the production of agranulocytosis: antibiotics, anti-inflammatory, anti-depressants, etc. Of these medicines metamizol has been one of the most closely-associated with this blood disorder. Widely used, metamizol, is very popular not only in medical circles, but also amongst patients who are able to buy it without prescription from any pharmacy in our country. Although the association between agranulocytosis and metamizol is not common, we should be aware of the grave consequences which may arise. This was the case of the patient described who, having taken metamizol, required urgent treatment at home, before being admitted to hospital. Emergency room analysis revealed agranulocitosis. The patient was admitted to the Intensive Care Unit where, in spite of support and anti-biotherapy, she died within a few hours. 

Palabras clave : Agranulocytosis; Anti-inflammatory agents; Non-steroidal; Dipyrone; Neutropenia; Side Effects; Mortality.

        · resumen en Español     · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons